The trademark application G-IVF was filed by Vitrolife Sweden AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on June 20, 2022, and it was registered by office on September 27, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1695819 at the World Intellectual Property Organization (WIPO).
The application was filed in Swedish (English was selected as the second language).